REGN10597
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REGN10597, covering 2025-12-15 to 2025-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body [Phase 1, Phase 2]